164 related articles for article (PubMed ID: 28702896)
1. Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model.
Rice MS; Tworoger SS; Hankinson SE; Tamimi RM; Eliassen AH; Willett WC; Colditz G; Rosner B
Breast Cancer Res Treat; 2017 Nov; 166(1):227-240. PubMed ID: 28702896
[TBL] [Abstract][Full Text] [Related]
2. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
[TBL] [Abstract][Full Text] [Related]
3. Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk.
Glynn RJ; Colditz GA; Tamimi RM; Chen WY; Hankinson SE; Willett WW; Rosner B
Breast Cancer Res Treat; 2017 Aug; 165(1):215-223. PubMed ID: 28589369
[TBL] [Abstract][Full Text] [Related]
4. Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study.
Rosner BA; Colditz GA; Hankinson SE; Sullivan-Halley J; Lacey JV; Bernstein L
Breast Cancer Res Treat; 2013 Nov; 142(1):187-202. PubMed ID: 24158759
[TBL] [Abstract][Full Text] [Related]
5. Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.
Tworoger SS; Zhang X; Eliassen AH; Qian J; Colditz GA; Willett WC; Rosner BA; Kraft P; Hankinson SE
J Clin Oncol; 2014 Oct; 32(28):3111-7. PubMed ID: 25135988
[TBL] [Abstract][Full Text] [Related]
6. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
7. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
[TBL] [Abstract][Full Text] [Related]
8. Red meat intake and risk of breast cancer among premenopausal women.
Cho E; Chen WY; Hunter DJ; Stampfer MJ; Colditz GA; Hankinson SE; Willett WC
Arch Intern Med; 2006 Nov; 166(20):2253-9. PubMed ID: 17101944
[TBL] [Abstract][Full Text] [Related]
9. Mammographic density and breast cancer risk: a mediation analysis.
Rice MS; Bertrand KA; VanderWeele TJ; Rosner BA; Liao X; Adami HO; Tamimi RM
Breast Cancer Res; 2016 Sep; 18(1):94. PubMed ID: 27654859
[TBL] [Abstract][Full Text] [Related]
10. Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk?
Eliassen AH; Missmer SA; Tworoger SS; Hankinson SE
J Clin Oncol; 2006 Apr; 24(12):1823-30. PubMed ID: 16567770
[TBL] [Abstract][Full Text] [Related]
11. Simplified Breast Risk Tool Integrating Questionnaire Risk Factors, Mammographic Density, and Polygenic Risk Score: Development and Validation.
Rosner B; Tamimi RM; Kraft P; Gao C; Mu Y; Scott C; Winham SJ; Vachon CM; Colditz GA
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):600-607. PubMed ID: 33277321
[TBL] [Abstract][Full Text] [Related]
12. The Association of Mammographic Density and Molecular Breast Cancer Subtype.
Edwards BL; Atkins KA; Stukenborg GJ; Novicoff WM; Larson KN; Cohn WF; Harvey JA; Schroen AT
Cancer Epidemiol Biomarkers Prev; 2017 Oct; 26(10):1487-1492. PubMed ID: 28698184
[No Abstract] [Full Text] [Related]
13. Percent mammographic density prediction: development of a model in the nurses' health studies.
Rice MS; Rosner BA; Tamimi RM
Cancer Causes Control; 2017 Jul; 28(7):677-684. PubMed ID: 28478536
[TBL] [Abstract][Full Text] [Related]
14. Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women.
Rosner B; Eliassen AH; Toriola AT; Hankinson SE; Willett WC; Natarajan L; Colditz GA
Breast Cancer Res Treat; 2015 Apr; 150(3):643-53. PubMed ID: 25796612
[TBL] [Abstract][Full Text] [Related]
15. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
[TBL] [Abstract][Full Text] [Related]
16. The association between China's Great famine and risk of breast cancer according to hormone receptor status: a hospital-based study.
Alimujiang A; Mo M; Liu Y; Huang NS; Liu G; Xu W; Wu J; Shen ZZ; Shao Z; Colditz GA
Breast Cancer Res Treat; 2016 Nov; 160(2):361-369. PubMed ID: 27696082
[TBL] [Abstract][Full Text] [Related]
17. Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors.
Parise CA; Caggiano V
Breast Cancer Res Treat; 2017 Oct; 165(3):743-750. PubMed ID: 28689363
[TBL] [Abstract][Full Text] [Related]
18. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
[TBL] [Abstract][Full Text] [Related]
19. Application of the Rosner-Colditz risk prediction model to estimate sexual orientation group disparities in breast cancer risk in a U.S. cohort of premenopausal women.
Austin SB; Pazaris MJ; Rosner B; Bowen D; Rich-Edwards J; Spiegelman D
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2201-8. PubMed ID: 23035180
[TBL] [Abstract][Full Text] [Related]
20. Body fatness throughout the life course and the incidence of premenopausal breast cancer.
Xue F; Rosner B; Eliassen H; Michels KB
Int J Epidemiol; 2016 Aug; 45(4):1103-1112. PubMed ID: 27466312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
